←
John Spertus137 posts
John Spertus avatar

John Spertus

@jspertus

#outcomesresearch

◷ Joined February 2009▧ 12 Photos and videos
Harlan Krumholz avatar
⟳ John Spertus retweeted
Harlan Krumholz@hmkyale·14 Nov 2021

Congrats to the #CHIEF_HF investigators…digital first trial, with drug, & for regulatory indication expansion. Canagliflozin improved quality of life in patients with heart failure. But the trial design even bigger news. Heralds new era in trial implementation. @jspertus #AHA21

Post attachmentPost attachment
John Spertus avatar
John Spertus@jspertus·6 Mar 2021

So excited to see the field move from using PROs as descriptive outcomes to a means of improving the patient-centeredness of care. @VHejjaji @MichaelNassifMD @djc795 @gcfmd @GreggWStone @CircOutcomes @hmkyale tctmd.com/news/beyond-resear…

Ritu Thamman MD avatar
⟳ John Spertus retweeted
Ritu Thamman MD@iamritu·17 May 2020

Thank you Michael Ho program chair of #QCOR20 & @bnallamo EIC of @CircOutcomes for a fantastic virtual @AHAMeetings & to all on planning committee @UmeshKhotMD @rashmeeushah & all expert faculty @TYWangMD @leftbundle @DrKLindley @ericpetersonMD @jspertus @kejoynt @jasonwasfy ++

Post attachment

Thank you for joining us at #QCOR20! Miss a session? Access through QCOR OnDemand for the next 90 days! Visit us in the #HeartHub year-round for curated content from AHA Journals and Science News, membership resources & Early Career content. hearthubs.org/qcor

Saint Luke's Mid America Heart Institute avatar
⟳ John Spertus retweeted
Saint Luke's Mid America Heart Institute@MidAmericaHeart·30 Mar 2020

The second is from ISCHEMIA-CKD and noted that nearly half of patients had no angina in the prior month. Even in patients with angina, the health status benefit with revascularization was transient and less significant than in the primary ISCHEMIA trial.

Post attachment
John Spertus avatar
John Spertus@jspertus·21 Mar 2020

Amazing email today for those on satellite internet from @ViasatInternet @ViasatInc. In a world where we have to work at home, no break on costs or fees for more access. I used mine up in a week and now on dial-up speed. Just criminal. #makingmoneyfromCovid

John Spertus avatar
John Spertus@jspertus·28 Feb 2020

Fabulous cutting edge initiative to understand the roles of new technology to improve human health. Thrilled to be part of this ground-breaking study with @CMichealGibson...

#JNJ, in collaboration with Apple, has launched the Heartline™ Study—a virtual research study using wearable technology & cutting-edge apps to help detect #AFib. Learn about the study & its potential to impact the up to 6 million in the U.S. with AFib: https://t.co/ZoFWHB2G0c

Post attachment
John Spertus avatar
John Spertus@jspertus·5 Jan 2020

So the week of Thanksgiving, the NEJM publishes a study on the benefits of intermittent fasting. On New Year’s they publish a study showing that alcohol abstinence reduces Afib. What are they going to publish on Valentine’s day?? ... Ponderings with @MichaelNassifMD @hmkyale

John Spertus avatar
John Spertus@jspertus·14 Dec 2018

I applaud UC for drawing attention to this. The quest for profits by Elsevier is impairing the sharing of science, which is our primary goal as researchers and scientists.

"Consider declining to review for Elsevier journals" Notice to All Faculty by Executive Vice Chancellor and Provost of University of California @UCsystem. Unprecedented! See chronicle.com/article/In-Tal… for more. #openaccess #bigdeals

Post attachment